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IMMUNOLOGIC STUDIES IN PATIENTS WITH SERUM
SICKNESS-LIKE REACTIONS FOLLOWING
PENICILLIN THERAPY*
MICHAEL J. FELLNER, M.D. AND RUDOLF L. BAER, M.D.
Recent advances have enlarged our concepts
regarding the mechanisms of adverse reactions
to penicillin in man. Prior to the discovery of
the benzylpenicilloyl haptenic grouping as the
major antigenic determinant of penicillin sensi-
tivity in man, efforts to detect potential allergic
reactors and to determine whether suspected
drug reactions could he proven to he due to
penicillin were based almost entirely on skin test-
ing with penicillin itself. Since immediate and de-
layed skin tests with penicillin per se were more
often negative than positive even in patients
with clinically unmistakable allergic reactions,
the practice of skin testing before administration
of the drug was never universally adopted be-
cause it was not sufficiently revealing and safe.
In addition, there have been no standards for
concentration of test materials or interpretation
of results. Re-awakening of interest in the field
has been stimulated by Levine's discovery of the
benzylpenicilloyl haptenic grouping (1) and by
the synthesis of penicilloyl-polylysine, a skin
test reagent composed of poly-L-amino acid
chains linked to penicilloyl groupings in the same
configuration in which this hapten is believed
to conjugate with human proteins in vivo in
most cases (1, 2).
In addition, an extremely sensitive technic
for the detection of specific antibodies to peni-
cillin derivatives has been developed recently
(3). This is a hemmagglutination test which is
capable of detecting as little as 1 x 10 gamma/
ml of IgG antibody protein in human sera. Uti-
lizing this method, penicilloyl-specific circulat-
ing antibodies were found in the sera of all 54
patients studied who had recently completed
courses of penicillin therapy without adverse
effect (3). Essentially, the technic depends
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on a phenomenon which is a covalent reaction
occurring within 1 hour between red cells and
penicillin at pH 9.5 in buffer. The method is as
follows: Sera to be tested are diluted in a mixture
of dextran and fetal calf serum which serves as
an amplification device by increasing rouleaux
formation and allowing alignment of red cells.
Penicillinized cells are mixed with serial dilutions
of serum and spun at 1,000 RPM for 1 minute
at 10° to 15°C. Readings are then performed by
manual tapping of the test tubes and observing
for gross clumping (3).
In addition to skin tests and antibody assays
by hemagglutination, lymphocyte tissue cultures
exposed to suspected drugs have been used as an
immunologic tool for the investigation of patients
with allergic reactions to drugs (4). Utilizing
all of these methods for the investigation of
immunologic responses following penicillin ther-
apy, we have investigated the course of 11
patients with serum sickness-like reactions
following penicillin over a period of time up to
2 years.
With improvements in preparation of skin test
reagents, many clinical investigators in the
U.S.A. have studied skin test responses in many
thousands of patients receiving penicillin (5, 6,
7, 8). The results of these studies indicate that
patients who have had anaphylactic episodes
from penicillin have positive wheal-and-fiare
skin tests to one or more penicillin derivatives
used and that those IgG and 1gM antibodies
which are demonstrable by hemagglutination are
not directly involved in the mechanism pro-
ducing such reactions (3, 5, 6, 7, 5, 9). In our
experience with patients over the last year,
there has not been a single anaphylactic re-
action following penicillin administration when
our skin tests with the same materials, namely,
penicillin and penicilloyl-polylysine, were nega-
tive. Moreover, the results of our studies in-
dicate that anaphylactic reactions are most
probably mediated by skin-sensitizing anti-
bodies of "minor" * group specificities, since in
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anaphylactic reactors most skin tests are posi-
tive with penicillin as such and not with peni-
cilloyl-polylysine, although a few show re-
activity to both materials (6). Thus, when both
penicillin to detect minor group specificity and
penieilloyl-polylysine to detect the major group
reactors have been used and when tests were
negative, there have been no anaphylactie re-
actions to administration of penicillin.
Although anaphylaetic reactions to penicillin
are the most serious, they are few in number.
Far greater in number are reactions other than
the anaphylaetic which occur several days after
administration of penicillin. These may be urti-
canal, serum sickness-like, exanthematie (e.g.
searlatiniform, morbilliform) eezematous, cry-
thema multiforme-like, or erythema nodosum-
like. One of the most common of these is
nrtiearia. Tlrticaria may occur alone or in com-
bination with other signs and symptoms.
The concept of serum sickness in man was
first defined by Von Pirquet and Schick in 1905
(10). Occurring usually within 8 to 12 days
following injection of serum, in addition to a
rash, which was most often urticanial but oc-
casionally morbilliform, they described fever,
lymphadenopathy, arthralgia, leukopenia, edema,
and albuminunia.
In the 1940s, effects were noted following
penicillin therapy which were similar to the
signs and symptoms seen in man following ad-
ministration of foreign serum (11). We will use
the term "serum sickness-like" to denote re-
actions occurring in man within 1 to 3 weeks
following initiation of penicillin therapy in which
either an eruption (most often urticanial) or
arthralgia is the predominant presenting feature
and is accompanied by any one of the following
findings: fever, proteinuria and periorbital or
other edema.
MATERIALS ANO METHOOS
Skin tests (12) hemagglutination (3), and lym-
phocyte cultures (4) were all performed as pre-
viously described.
TABLE I
Results of immediate skin tests with penicillin* and
penicilioylpolylysine** in patients during and
after serum sickness-like reactions following
penicillin therapy
+ PGt
+ PG
+ PPL
+ PG
+ PPL
Not done
+ PG
+ PG
+ PG
+ PPL
* Penicillin: PG, 0.02M (approximately 10,000
u/mI).
** Penicilloyl-polylysine: PPL, 6 X 10 M.
t This patient showed a wheal-and-flare reac-
tion to PPL at 50 minutes.
Of 11 patients studied, 7 were seen by us dur-
ing the acute phases of their illness and were skin
tested for the first time then and several times
subsequently. The other 4 cases were seen by
resident physicians during the acute phases of the
disease; they were usually seen by us shortly
afterwards, but in no case later than 4 weeks after
subsidence of the clinical manifestations. Tests
were done as early as possible and at intervals
thereafter.
RESULTS
Table I shows that 5 of the 7 patients tested
during the acute, symptomatic phase had nega-
tive skin tests. However, all 11 patients had
positive immediate skin test reactions to either
penicillin or penicilloyl-polylysine when tests
were performed within one to four weeks after
the serum sickness-like reaction had subsided.
We were able to re-test 7 patients 2 months to
2 years after the serum sickness-like reaction,
and all showed persistence of wheal-and-flare
reactivity.
Two patients (J.M. and HG.) showed changes
in specificity of the response. J.M. originally
had a positive test with penicillin alone; on
follow-up 1 year later he reacted to penieilloyl-
polylysine but not to penicillin. On the other
hand HG. had reacted to penieilloyl-polylysine
Patient During acute After recovery
phase (1 to 4 weeks)
+ PG
+ PPL
1
2
3
4
5
6
7
8
9
10
11
Negative
Negative
Negative
Negative
Negative
+ PPI
+ PPL
Not done
Not done
Not done
Not done
After an additional
interval of
Not done
8 mos. + PPL
+ PG
25 mos. + PG
1 mo. + PG
8 mos. + PPL
Not done
Not done
26 mos. + PG
21 mos. + PG
12 mos. + PPL
2 mos. + PPL
called the "maj or" antigenie determinant because
it is involved in most eases of penicillin sensitiv-
ity (9). Skin-sensitizing antibodies specific for this
determinant may be detected by skin tests with
penicilloyl-polylysine. However, skin-sensitizing
antibodies may be detected by skin testing with
penicillin G itself or with other penicillin deriva-
tives. These other antigenie determinants of peni-
cillin sensitivity have been termed "minor" deter-
minants by Levine (9). In this study we used
oenieillin G to detect such antibodies.
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TABLE II
Reciprocal hemagglutination titers of antipenicil-
loyl-antibodies in patients with positive imme-
diate skin tests following serum sickness-like
reactions to penicillin
After 2-
Mercap-
toeth-
anol re-
duction
2,048
32,768
8,192
1,024
256
0
32
256
64
4,096
0
* Abbreviations: HA, hemagglutination; PG,
penicillin; PPL, penicilloyl-polylysine.
** These are the titers obtained on first evalua-
tion of patients after their clinical reactions.
t This patient had a positive wheal-and-flare
with PPL at 50 minutes.
within one week of her clinical reaction, but
when tested 9 months later reacted to both
penicillin and periicilloyl-polylysine. At the time
of this test she also developed symptoms of
an anaphylactic reaction in the form of tachy-
cardia, difficulty in breathing, hypotension, and
generalized urticaria. Figure 1 depicts the clinical
and immunologic sequence over a period of
observation of 9 months in this unusual patient.
Table II illustrates that all patients with
positive immediate skin tests to penicilloyl-
polylysine had IgG antibodies detectable by
hemagglutination. The levels of antibodies were
high, ranging from 1/256 to 1/32,786. While
serums were drawn at the earliest possible date
after the clinical reaction, there were consider-
able differences for individual patients in the
time period intervening between the serum
sickness-like reaction and the first hemaggluti-
nation assay.
Patients with positive skin responses to peni-
cillin alone had predominantly 1gM antibodies in
contrast to those with positive skin tests to peru-
cilloyl-polylysinc who had IgG. The two excep-
tions to this are patients R.H. and J.M. RH.,
with a positive immediate skin test to penicillin
who had a high IgG hemagglutination titer,
1/4096, showed a whcal-and-flare skin test reac-
tion with penicilloyl-polylysine which appeared
within 50 minutes of testing. J.M., with a posi-
tive immediate skin test to penicillin and an ab-
Patient
1
2
3
4
5
6
7
8
9
10
11
Skin test
PPL
PPL
PPL
PPL & PG
PPL
PG
PG
PG
PG
PGt
PG
Recip-
rocal
HA
titer**
2,048
32,768
8,192
1,024
256
512
2,048
512
512
4,096
128
Predominant
antibody
IgG
IgG
IgG
IgG
IgG
1gM
1gM
1gM & IgG
1gM
IgG
1gM
2012 —fl ANTIBODY STUDIES IN A PATIENT WITH A SERUM
SICKNESS-LIKE REACTION AFTER PEN IC I ILIN
HA titers
-
14
512
256H U U 9 9 0
Serum Occasional Anaphylaxis
sickness hives hives
Symptoms I
I I I I I
Monthaflerreaction I 2 3 4 5 6 7 8 9
Skin tests:
PenG5Ou — —
— +
BPO-PLL + + + +
-I-
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normally high titer of IgG antibodies, developed
a positive immediate skin response to penicilloyl-
polylysine later on (see Table I) and a negative
test to penicillin. In general, patients with ini-
tially high titers of circulating hemagglutinating
IgG antibodies, showed declining titers when fol-
lowed for a period of a year or more. In con-
trast, patients with initially low titers, usually
1gM, showed no change in titers later.
There was striking persistence of skin-sensi-
tizing antibodies as detected by direct skin test-
ing in all patients followed for 2 to 26 months.
All 4 patients followed for 1 year or more showed
persistence of cutaneous reaction to penicillin or
penicilloyl-polylysine. The intensity of the skin
test response was diminished in only 1 of the
4 patients.
Lymphocyte Stimulation Tests: Lymphocytes
for cultures were obtained from 4 of the pa-
tients. Preparations from all showed an effect
from stimulation with penicillin ranging between
8% and 24% above control values. In 2 patients
cultures of lymphocytes were repeated over a 1
month interval with no appreciable change in
results.
DISCUsSION
In previous studies of 76 patients selected at
random, some of whom denied ever having re-
ceived penicillin therapy, 97% had hemag-
glutinating antibodies to penicillin, mainly low
titers (1/128 or less) of 1gM, and only 3% had
skin-sensitizing antibodies as detected by direct
skin tests (6, 12). The latter figure is in good
agreement with figures of others ranging be-
tween 4 and 7 percent (2, 8). In contrast, skin-
sensitizing antibodies were found by direct skin
tests in all of 6 previously studied patients with
anaphylactic reactions to penicillin (6, 12). The
specificity of most of these antibodies was di-
rected against the minor determinants except for
2 unusual reactors whose case reports are to be
published separately.
Our findings in the present study of 11 pa-
tients with serum sickness-like reactions were
distinctly different from those found in the
anaphylactic reactors to penicillin and in pa-
tients selected at random. Table III lists some
of the salient similarities and differences be-
tween serum sickness-like and anaphylactic re-
actions. All of the patients with serum sickness
had skin-sensitizing antibodies, as do anaphylac-
tic reactors. However, in about one half of the
"Major"
(BPO) or
"Minor"
(PG or other)
Often negative
during acute
phase.
All positive
later on
Stimulatory
effect with
PG
Often high
titers IgG
Skin-sensitiz- Skin-sensitiz-
ing antibody ing antibody
patients with serum sickness the specificity of
these antibodies was directed against the peni-
cilloyl determinant and in the other half against
penicillin itself. In contrast, in anaphylactic re-
actors the minor antigenic determinants are al-
most always involved (9, 12). It is noteworthy
also that 5 of 7 serum sickness patients who were
tested during the acute phase gave negative skin
tests to penicillin and pcnicilloyl-polylysinc,
while the 2 patients who did react had skin test
reactions to penicilloyl-polylysine rather than to
penicillin. However, 1 to 4 weeks after sub-
sidence of the serum sickness-like reactions all
those who were tested gave positive skin test re-
TABLE III
Comparison of immunologic and other features of
serum sickness-like and anaphylaclic
reactions following penicillin in man
Serum sickness-like Anaphylactic
Practically all
''Minor''
All positive
Stimulatory ef-
fect with PG
Usually low
titers but no
definite pat-
tern
Repeated expo-
sure needed
Small (may be
10 units PG
or less)
Antigenic De-
terminant
Wheal-and-
Flare Reac-
tions
Lymphocyte
Culture
Hcmaggluti-
nating Anti-
bodies
Number of ex-
posures Re-
quired
Threshold Dose
Required to
Elicit Reac-
tion
Type of Anti-
body Mediat-
ing Reaction
Theory of
Mechanism
Cutaneous
Changes
May occur with
first exposure
Relatively
large
Antigen-anti-
body com-
plexes in
antigen ex-
cess
Almost always
accompanied
by urticaria
Simple bridg-
ing of tissue-
fixed SSA by
multivalent
hapten
May be accom-
panied by
urticaria
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actions to penicillin or penicilloyl-polylysine. In
contrast again, we have never observed nega-
tive skin tests in anaphylactic reactors to peni-
cillin in skin tests done within hours to days af-
ter the clinical episode (6, 12).
Recently a new syndrome of recurrent urti-
caria and arthralgia has been described in 16 pa-
tients treated with penicillin who had no evi-
dence of fever or other systemic involvement
(12). It is not clear whether the arthralgia was
really due to edema of the skin at the joint sites.
All patients developed reactions only after peni-
cillin had been discontinued. The subjects of the
present report differ from the patients with this
syndrome of recurrent urticaria in several re-
spects. In general, our own cases conform more
closely to that of the reactions described fol-
lowing serum administration. Differences from
recurrent urticaria and arthralgia are: 1. Lack
of definite recurrent pattern except in 2 patients
who were repeatedly skin tested; 2. Develop-
ment of reaction in 2 patients still taking peni-
cillin; 3. Albuminuria in 2 patients; 4. "Minor"
skin-sensitizing antibodies in 7 of 11 of our pa-
tients compared to all those in the recurrent urti-
caria and arthralgia group. In addition, biopsy
specimens in 4 of our patients showed eosino-
philia in perivascular infiltrates. In addition, 1
patient had a 6% blood cosinophilia.
Although it has been accepted for some time
that the lesions of serum sickness are associated
with antigen-antibody complexes (13), the na-
ture of the antibody involved has not been defi-
nitely known. Von Pirquet and Schick noted
the presence of precipitating antibodies in the
serums of a great number of their patients (10).
Reisman et al. (14) commented on the produc-
tion of distinct and separate skin-sensitizing and
precipitating antibodies in serum disease and
suggested that the skin-sensitizing antibodies
might play an important role. However, they
felt its role was not clear.
Our findings suggest that serum sickness-like
reactions to penicillin in man are mediated by
skin-sensitizing antibodies, i.e., the same class of
antibodes thought to mediate anaphylactic re-
actions. Therefore, the very different clinical
manifestations of these two reactions must be
accounted for by factors other than the class of
antibodies which mediates the reaction. Such
differences most likely involve antibody speci-
fleity for different determinant groups and the
requirement for tissue fixation of antibody for
elicitation of anaphylaxis.
Work on the mechanism of immediate allergic
wheal-and-fiare reactions in man indicates that
multivalent benzylpenicilloyl hapten bridges 2 or
a small number of tissue fixed skin-sensitizing
antibody molecules to form relatively simple
complexes of the composition H (bapten)1 Ab
(antibody) n where n is a small number (15).
The finding of negative skin tests to penicillin 0
and penicilloyl-polylysine in most cases of peni-
cillin serum sickness during the acute phase of
the reaction could be explained by the possibil-
ity that most or all of the available skin-sensi-
tizing antibodies are already bound by antigen
previously administered and thus arc not avail-
able for union with the antigen administered by
the intracutaneous test injection. This fits in
well with the hypothesis that serum sickness-like
reactions arc produced by antigen-antibody com-
plexes in antigen excess. However, there are
other possible explanations, among them that
antibodies may be present in the skin in too
low a concentration to be detectable by skin
testing or antibodies may be present in the cir-
culation but not yet fixed to the skin. The fact
that serum sickness-like reactions usually are
seen after the administration of large doses of
penicillin, while anaphylactic reactions may oc-
cur after minute doses is also in agreement with
this hypothesis.
Despite these differences there are also certain
observations which suggest that close relation-
ships exist between these two types of allergic
hypersensitivity. This would be expected if our
hypothesis is correct that both types of reac-
tion are mediated by the same class of anti-
bodies. For example, urticarial lesions are com-
mon to both forms of reaction. In addition, the
sequence of events in one case (Fig. 1) can be
interpreted to illustrate the close clinical rela-
tionship between the serum sickness-like and
anaphylactic reactions. The patient, after hav-
ing had a serum sickness-like reaction was skin
tested 4 times during a 9 month period of fol-
low-up, receiving about 50 units of penicillin 0
and approximately 6 x 10'° moles of penicilloyl-
polylysine. While the patient always reacted to
penicilloyl-polylysine during this period and had
high titers of circulating antipenicilloyl Igo anti-
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bodies there was no skin test reaction with peni-
cillin G. The first positive skin test to penicillin
G was just prior to the anaphylactic reaction. At
that time the IgG antibody titer was at its low-
est. It has been suggested that IgG penicilloyl-
specific antibodies may compete with skin-sensi-
tizing antibodies of the same specificity for
antigen, acting as "blocking antibodies", pro-
tecting against immediate allergic reactions (16).
Our observations of striking persistence of
skin-sensitizing antibody activity in patients
with serum sickness-like reactions to penicillin
arc in contrast with the observed decreases in
titers of IgG antibodies over a period of months
to years. Truitt's observations on skin reactivity
were similar (17). His patient had a positive di-
rect skin test with penicillin following a serum
sickness-like reaction and still reacted to skin
tests with penicillin nine months after the dis-
ease had subsided. On the other hand Finke and
his group, in their cases of "late allergic" and
other reactions, found a decrease in skin test re-
activity to penicillin with increasing time (18).
However, in their study, many different varieties
of clinical allergic reactions were included and
many patients were accepted as allergic to peni-
cillin on the basis of history alone.
Our findings are in agreement with Reisman's
observations of persistence of positive direct skin
tests to horse serum over long periods of time
in patients who have had serum disease fol-
lowing administration of tetanus antitoxin (19).
Schmidt, Robinson and Pcnnypackcr (20) de-
scribed a patient with a serum sickness reaction
to diphtheria antitoxin who also showed per-
sistence of positive skin tests. In addition, these
authors observed the presence of precipitating
antibodies to diphtheria antitoxin. However,
they ascribed the role of mediator of the symp-
toms of the reaction to reaginic antibody.
SUMMARY
The results of these studies suggest that se-
rum sickness-like reactions to penicillin in man
are mediated by skin-sensitizing antibodies.
Eleven patents with such reactions had positive
immediate skin tests to penicillin G or its
derivatives, which persisted up to 2 years.
Lymphocyte cultures with penicillin G showed
a stimulatory effect in all 4 patients studied.
IgO and 1gM penicilloyl-specific antibodies de-
tectable by hemagglutination did not appear to
be involved in pathogenesis of serum sickness-
like reactions. The similarities and differences
between the anaphylactic and serum sickness-
like reactions following penicillin arc sum-
marized.
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